nodes	percent_of_prediction	percent_of_DWPC	metapath
Danazol—GNRHR—adrenal gland cancer	0.888	1	CbGaD
Danazol—CCL2—brown adipose tissue—adrenal gland cancer	0.0123	0.333	CbGeAlD
Danazol—GNRHR—gonad—adrenal gland cancer	0.00219	0.0592	CbGeAlD
Danazol—GNRHR—pituitary gland—adrenal gland cancer	0.00214	0.0578	CbGeAlD
Danazol—CCL2—adrenal cortex—adrenal gland cancer	0.00207	0.0558	CbGeAlD
Danazol—CYP3A4—urine—adrenal gland cancer	0.00179	0.0483	CbGeAlD
Danazol—CCL2—cardiac atrium—adrenal gland cancer	0.00171	0.0462	CbGeAlD
Danazol—CCL2—pituitary gland—adrenal gland cancer	0.00167	0.0451	CbGeAlD
Danazol—CCL2—adrenal gland—adrenal gland cancer	0.00149	0.0403	CbGeAlD
Danazol—SHBG—gonad—adrenal gland cancer	0.000999	0.027	CbGeAlD
Danazol—SHBG—pituitary gland—adrenal gland cancer	0.000974	0.0263	CbGeAlD
Danazol—PGR—pituitary gland—adrenal gland cancer	0.000878	0.0237	CbGeAlD
Danazol—SHBG—adrenal gland—adrenal gland cancer	0.00087	0.0235	CbGeAlD
Danazol—AR—adrenal cortex—adrenal gland cancer	0.000865	0.0234	CbGeAlD
Danazol—CYP19A1—gonad—adrenal gland cancer	0.00081	0.0219	CbGeAlD
Danazol—PGR—adrenal gland—adrenal gland cancer	0.000784	0.0212	CbGeAlD
Danazol—AR—gonad—adrenal gland cancer	0.000717	0.0194	CbGeAlD
Danazol—AR—cardiac atrium—adrenal gland cancer	0.000716	0.0193	CbGeAlD
Danazol—CYP19A1—adrenal gland—adrenal gland cancer	0.000706	0.0191	CbGeAlD
Danazol—ESR1—gonad—adrenal gland cancer	0.000704	0.019	CbGeAlD
Danazol—AR—pituitary gland—adrenal gland cancer	0.000699	0.0189	CbGeAlD
Danazol—ESR1—pituitary gland—adrenal gland cancer	0.000687	0.0185	CbGeAlD
Danazol—AR—adrenal gland—adrenal gland cancer	0.000625	0.0169	CbGeAlD
Danazol—ESR1—adrenal gland—adrenal gland cancer	0.000613	0.0166	CbGeAlD
Danazol—CCL2—TNF alpha Signaling Pathway—BAD—adrenal gland cancer	0.000451	0.00603	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000447	0.00598	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.000442	0.0059	CbGpPWpGaD
Danazol—ESR1—Estrogen signaling pathway—BRAF—adrenal gland cancer	0.000422	0.00564	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—GNRH1—adrenal gland cancer	0.000409	0.00547	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000399	0.00533	CbGpPWpGaD
Danazol—ESR1—Plasma membrane estrogen receptor signaling—IGF1R—adrenal gland cancer	0.000389	0.00521	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.000369	0.00494	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000369	0.00494	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—TSHR—adrenal gland cancer	0.000365	0.00488	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of steroid hormones and vitamin D—POMC—adrenal gland cancer	0.000357	0.00478	CbGpPWpGaD
Danazol—CCL2—Selenium Micronutrient Network—PTGS2—adrenal gland cancer	0.000344	0.0046	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000343	0.00459	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000341	0.00456	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—RB1—adrenal gland cancer	0.000331	0.00442	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—GNRH1—adrenal gland cancer	0.000312	0.00417	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—TSHR—adrenal gland cancer	0.000304	0.00406	CbGpPWpGaD
Danazol—AR—Notch-mediated HES/HEY network—RB1—adrenal gland cancer	0.000304	0.00406	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—GNRHR—adrenal gland cancer	0.000292	0.0039	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—CDC42—adrenal gland cancer	0.000292	0.0039	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—DAXX—adrenal gland cancer	0.000284	0.0038	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—TSHR—adrenal gland cancer	0.000278	0.00371	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.000278	0.00371	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—PTGS2—adrenal gland cancer	0.000272	0.00363	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—RRM1—adrenal gland cancer	0.000264	0.00354	CbGpPWpGaD
Danazol—CCL2—Oncostatin M Signaling Pathway—TP53—adrenal gland cancer	0.000261	0.00349	CbGpPWpGaD
Danazol—CYP3A4—Drug Induction of Bile Acid Pathway—ABCB1—adrenal gland cancer	0.000258	0.00345	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—CDC42—adrenal gland cancer	0.000258	0.00345	CbGpPWpGaD
Danazol—CCL2—Folate Metabolism—TP53—adrenal gland cancer	0.000258	0.00344	CbGpPWpGaD
Danazol—ESR1—FOXM1 transcription factor network—RB1—adrenal gland cancer	0.000256	0.00342	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—TERT—adrenal gland cancer	0.000255	0.00341	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—REN—adrenal gland cancer	0.000251	0.00336	CbGpPWpGaD
Danazol—CCL2—AP-1 transcription factor network—TP53—adrenal gland cancer	0.000246	0.00329	CbGpPWpGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—PTGS2—adrenal gland cancer	0.000243	0.00325	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—RB1—adrenal gland cancer	0.000238	0.00318	CbGpPWpGaD
Danazol—CCL2—Peptide ligand-binding receptors—POMC—adrenal gland cancer	0.000233	0.00311	CbGpPWpGaD
Danazol—ESR1—FOXM1 transcription factor network—CDKN2A—adrenal gland cancer	0.000225	0.00301	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—TERT—adrenal gland cancer	0.000224	0.00299	CbGpPWpGaD
Danazol—CYP19A1—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	0.000221	0.00296	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—PRKACA—adrenal gland cancer	0.00022	0.00294	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—CDKN2A—adrenal gland cancer	0.000217	0.0029	CbGpPWpGaD
Danazol—CCL2—Ectoderm Differentiation—CTNNB1—adrenal gland cancer	0.000215	0.00287	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000212	0.00284	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.000212	0.00283	CbGpPWpGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—PTGS2—adrenal gland cancer	0.000196	0.00261	CbGpPWpGaD
Danazol—ESR1—ATF-2 transcription factor network—RB1—adrenal gland cancer	0.000195	0.00261	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—EGFR—adrenal gland cancer	0.000193	0.00258	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.000191	0.00256	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—RB1—adrenal gland cancer	0.000182	0.00244	CbGpPWpGaD
Danazol—AR—Coregulation of Androgen receptor activity—CTNNB1—adrenal gland cancer	0.000181	0.00242	CbGpPWpGaD
Danazol—ESR1—Leptin signaling pathway—BAD—adrenal gland cancer	0.00018	0.0024	CbGpPWpGaD
Danazol—CYP19A1—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	0.00018	0.0024	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—GNAS—adrenal gland cancer	0.000177	0.00236	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—GNRH1—adrenal gland cancer	0.000176	0.00235	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—GNRH1—adrenal gland cancer	0.000175	0.00234	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CDKN2A—adrenal gland cancer	0.000174	0.00233	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—BAD—adrenal gland cancer	0.000174	0.00233	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GNRHR—adrenal gland cancer	0.000172	0.00231	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MED12—adrenal gland cancer	0.000167	0.00223	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.000164	0.0022	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TOP2A—adrenal gland cancer	0.000163	0.00218	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—NR5A1—adrenal gland cancer	0.000163	0.00218	CbGpPWpGaD
Danazol—CCL2—Spinal Cord Injury—TP53—adrenal gland cancer	0.000162	0.00216	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—GNAS—adrenal gland cancer	0.000162	0.00216	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.00016	0.00214	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—GNRH1—adrenal gland cancer	0.00016	0.00214	CbGpPWpGaD
Danazol—PGR—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.000159	0.00213	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—TSHR—adrenal gland cancer	0.000157	0.0021	CbGpPWpGaD
Danazol—CCL2—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000156	0.00209	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—TSHR—adrenal gland cancer	0.000156	0.00208	CbGpPWpGaD
Danazol—CYP3A4—Constitutive Androstane Receptor Pathway—ABCB1—adrenal gland cancer	0.000156	0.00208	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000151	0.00201	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CDKN2A—adrenal gland cancer	0.000149	0.002	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000149	0.00199	CbGpPWpGaD
Danazol—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCB1—adrenal gland cancer	0.000148	0.00198	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CDC42—adrenal gland cancer	0.000147	0.00197	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SH3KBP1—adrenal gland cancer	0.000147	0.00196	CbGpPWpGaD
Danazol—AR—Regulation of nuclear beta catenin signaling and target gene transcription—CTNNB1—adrenal gland cancer	0.000146	0.00195	CbGpPWpGaD
Danazol—Ethinyl Estradiol—ABCB1—adrenal gland cancer	0.000146	0.212	CrCbGaD
Danazol—ESR1—Signaling mediated by p38-alpha and p38-beta—TP53—adrenal gland cancer	0.000145	0.00194	CbGpPWpGaD
Danazol—GNRHR—Class A/1 (Rhodopsin-like receptors)—POMC—adrenal gland cancer	0.000143	0.00191	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—TSHR—adrenal gland cancer	0.000143	0.00191	CbGpPWpGaD
Danazol—Prednisone—ABCB1—adrenal gland cancer	0.000142	0.207	CrCbGaD
Danazol—Norethindrone—ABCB1—adrenal gland cancer	0.00014	0.204	CrCbGaD
Danazol—ESR1—Aryl Hydrocarbon Receptor—EGFR—adrenal gland cancer	0.000139	0.00185	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—ZNRF3—adrenal gland cancer	0.000138	0.00184	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—CTNNB1—adrenal gland cancer	0.000134	0.00179	CbGpPWpGaD
Danazol—PGR—Gene Expression—NR5A1—adrenal gland cancer	0.000134	0.00179	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.000133	0.00178	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MED12—adrenal gland cancer	0.000127	0.0017	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—IGF2—adrenal gland cancer	0.000125	0.00168	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—CTNNB1—adrenal gland cancer	0.000125	0.00167	CbGpPWpGaD
Danazol—ESR1—LKB1 signaling events—TP53—adrenal gland cancer	0.000123	0.00164	CbGpPWpGaD
Danazol—AR—Generic Transcription Pathway—MEN1—adrenal gland cancer	0.000122	0.00162	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.000121	0.00162	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.000119	0.0016	CbGpPWpGaD
Danazol—CCL2—GPCR ligand binding—POMC—adrenal gland cancer	0.000119	0.00159	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.000115	0.00153	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—ABCB1—adrenal gland cancer	0.000114	0.00153	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000112	0.0015	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	0.000111	0.00148	CbGpPWpGaD
Danazol—GNRHR—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—adrenal gland cancer	0.000109	0.00146	CbGpPWpGaD
Danazol—GNRHR—GPCR ligand binding—POMC—adrenal gland cancer	0.000109	0.00145	CbGpPWpGaD
Danazol—AR—Androgen receptor signaling pathway—EGFR—adrenal gland cancer	0.000106	0.00142	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	0.000104	0.0014	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GNRH1—adrenal gland cancer	0.000103	0.00138	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—BAD—adrenal gland cancer	0.000103	0.00137	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	0.000103	0.00137	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—PRKACA—adrenal gland cancer	0.000102	0.00137	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—BAD—adrenal gland cancer	0.000102	0.00137	CbGpPWpGaD
Danazol—AR—Gene Expression—NR5A1—adrenal gland cancer	0.000102	0.00136	CbGpPWpGaD
Danazol—ESR1—Regulation of Telomerase—EGFR—adrenal gland cancer	0.000101	0.00136	CbGpPWpGaD
Danazol—Hydrocortisone—ABCB1—adrenal gland cancer	0.0001	0.146	CrCbGaD
Danazol—PGR—Signaling Pathways—GNRHR—adrenal gland cancer	9.95e-05	0.00133	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MED12—adrenal gland cancer	9.79e-05	0.00131	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—CDC42—adrenal gland cancer	9.56e-05	0.00128	CbGpPWpGaD
Danazol—CYP19A1—Biological oxidations—POMC—adrenal gland cancer	9.54e-05	0.00127	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—CDC42—adrenal gland cancer	9.49e-05	0.00127	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—SPRY2—adrenal gland cancer	9.45e-05	0.00126	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GNRH1—adrenal gland cancer	9.45e-05	0.00126	CbGpPWpGaD
Danazol—ESR1—Generic Transcription Pathway—MEN1—adrenal gland cancer	9.36e-05	0.00125	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—BRAF—adrenal gland cancer	9.35e-05	0.00125	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SH3KBP1—adrenal gland cancer	9.25e-05	0.00124	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TSHR—adrenal gland cancer	9.21e-05	0.00123	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—MED12—adrenal gland cancer	9.2e-05	0.00123	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—RB1—adrenal gland cancer	9.19e-05	0.00123	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—GNAS—adrenal gland cancer	9.13e-05	0.00122	CbGpPWpGaD
Danazol—PGR—Signaling by ERBB4—EGFR—adrenal gland cancer	9.08e-05	0.00121	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—GNAS—adrenal gland cancer	9.07e-05	0.00121	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	8.78e-05	0.00117	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—ZNRF3—adrenal gland cancer	8.69e-05	0.00116	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—CDC42—adrenal gland cancer	8.68e-05	0.00116	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—MEN1—adrenal gland cancer	8.66e-05	0.00116	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—SPRY2—adrenal gland cancer	8.64e-05	0.00116	CbGpPWpGaD
Danazol—AR—SIDS Susceptibility Pathways—CTNNB1—adrenal gland cancer	8.55e-05	0.00114	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SDHB—adrenal gland cancer	8.53e-05	0.00114	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—BAD—adrenal gland cancer	8.52e-05	0.00114	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TSHR—adrenal gland cancer	8.42e-05	0.00113	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—POMC—adrenal gland cancer	8.37e-05	0.00112	CbGpPWpGaD
Danazol—ESR1—AP-1 transcription factor network—TP53—adrenal gland cancer	8.32e-05	0.00111	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—GNAS—adrenal gland cancer	8.29e-05	0.00111	CbGpPWpGaD
Danazol—Progesterone—ABCB1—adrenal gland cancer	8.16e-05	0.119	CrCbGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	8.13e-05	0.00109	CbGpPWpGaD
Danazol—PGR—Gene Expression—MED12—adrenal gland cancer	8.04e-05	0.00107	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—MEN1—adrenal gland cancer	7.92e-05	0.00106	CbGpPWpGaD
Danazol—ESR1—Gene Expression—NR5A1—adrenal gland cancer	7.85e-05	0.00105	CbGpPWpGaD
Danazol—Testosterone—ABCB1—adrenal gland cancer	7.71e-05	0.112	CrCbGaD
Danazol—PGR—Gene Expression—MEN1—adrenal gland cancer	7.68e-05	0.00103	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	7.55e-05	0.00101	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	7.27e-05	0.000972	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	6.95e-05	0.00093	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—CTNNB1—adrenal gland cancer	6.76e-05	0.000904	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PRKACA—adrenal gland cancer	6.71e-05	0.000897	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—PRKACA—adrenal gland cancer	6.61e-05	0.000883	CbGpPWpGaD
Danazol—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—adrenal gland cancer	6.46e-05	0.000864	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—PTGS2—adrenal gland cancer	6.26e-05	0.000837	CbGpPWpGaD
Danazol—GNRHR—GPCR downstream signaling—POMC—adrenal gland cancer	6.15e-05	0.000822	CbGpPWpGaD
Danazol—AR—Gene Expression—MED12—adrenal gland cancer	6.12e-05	0.000818	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—POMC—adrenal gland cancer	6.1e-05	0.000816	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—PRKACA—adrenal gland cancer	6.04e-05	0.000808	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	5.98e-05	0.0008	CbGpPWpGaD
Danazol—CCL2—Metabolism of proteins—CTNNB1—adrenal gland cancer	5.97e-05	0.000798	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GNRH1—adrenal gland cancer	5.96e-05	0.000796	CbGpPWpGaD
Danazol—AR—Gene Expression—MEN1—adrenal gland cancer	5.85e-05	0.000782	CbGpPWpGaD
Danazol—AR—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	5.84e-05	0.00078	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNRHR—adrenal gland cancer	5.84e-05	0.00078	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	5.76e-05	0.00077	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CDC42—adrenal gland cancer	5.61e-05	0.000749	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—CTNNB1—adrenal gland cancer	5.6e-05	0.000749	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—POMC—adrenal gland cancer	5.58e-05	0.000746	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—RRM1—adrenal gland cancer	5.49e-05	0.000734	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—SDHD—adrenal gland cancer	5.49e-05	0.000734	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—SPRY2—adrenal gland cancer	5.45e-05	0.000728	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SH3KBP1—adrenal gland cancer	5.43e-05	0.000725	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF2—adrenal gland cancer	5.4e-05	0.000722	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—EGFR—adrenal gland cancer	5.36e-05	0.000716	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—GNAS—adrenal gland cancer	5.36e-05	0.000716	CbGpPWpGaD
Danazol—ESR1—Signaling by ERBB4—EGFR—adrenal gland cancer	5.33e-05	0.000712	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TSHR—adrenal gland cancer	5.31e-05	0.00071	CbGpPWpGaD
Danazol—CYP3A4—Phase 1 - Functionalization of compounds—POMC—adrenal gland cancer	5.24e-05	0.0007	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—IGF1R—adrenal gland cancer	5.22e-05	0.000698	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CDC42—adrenal gland cancer	5.13e-05	0.000685	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—ZNRF3—adrenal gland cancer	5.1e-05	0.000682	CbGpPWpGaD
Danazol—CYP19A1—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	5.02e-05	0.000672	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—MEN1—adrenal gland cancer	4.99e-05	0.000667	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF2—adrenal gland cancer	4.94e-05	0.000661	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—GNAS—adrenal gland cancer	4.9e-05	0.000655	CbGpPWpGaD
Danazol—AR—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	4.84e-05	0.000647	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—IGF1R—adrenal gland cancer	4.78e-05	0.000639	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MED12—adrenal gland cancer	4.72e-05	0.00063	CbGpPWpGaD
Danazol—ESR1—Gene Expression—MEN1—adrenal gland cancer	4.51e-05	0.000602	CbGpPWpGaD
Danazol—ESR1—Integrated Breast Cancer Pathway—TP53—adrenal gland cancer	4.5e-05	0.000601	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TERT—adrenal gland cancer	4.5e-05	0.000601	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—EGFR—adrenal gland cancer	4.44e-05	0.000593	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TERT—adrenal gland cancer	4.11e-05	0.00055	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—MED12—adrenal gland cancer	4.1e-05	0.000548	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—BAD—adrenal gland cancer	3.91e-05	0.000523	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—PRKACA—adrenal gland cancer	3.81e-05	0.000509	CbGpPWpGaD
Danazol—ESR1—Integrated Pancreatic Cancer Pathway—TP53—adrenal gland cancer	3.73e-05	0.000498	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—POMC—adrenal gland cancer	3.66e-05	0.000489	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—POMC—adrenal gland cancer	3.61e-05	0.000482	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—BAD—adrenal gland cancer	3.58e-05	0.000478	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—BRAF—adrenal gland cancer	3.56e-05	0.000476	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNRH1—adrenal gland cancer	3.5e-05	0.000467	CbGpPWpGaD
Danazol—CCL2—Signaling by GPCR—EGFR—adrenal gland cancer	3.45e-05	0.000461	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—POMC—adrenal gland cancer	3.3e-05	0.000441	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—BRAF—adrenal gland cancer	3.26e-05	0.000435	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CDC42—adrenal gland cancer	3.23e-05	0.000432	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—SPRY2—adrenal gland cancer	3.2e-05	0.000428	CbGpPWpGaD
Danazol—GNRHR—Signaling by GPCR—EGFR—adrenal gland cancer	3.16e-05	0.000422	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TSHR—adrenal gland cancer	3.12e-05	0.000417	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF2—adrenal gland cancer	3.12e-05	0.000417	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—GNAS—adrenal gland cancer	3.09e-05	0.000413	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—IGF1R—adrenal gland cancer	3.01e-05	0.000403	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PRKACA—adrenal gland cancer	2.99e-05	0.000399	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—MEN1—adrenal gland cancer	2.93e-05	0.000392	CbGpPWpGaD
Danazol—CYP19A1—Metabolism of lipids and lipoproteins—PTGS2—adrenal gland cancer	2.92e-05	0.00039	CbGpPWpGaD
Danazol—CYP3A4—Biological oxidations—POMC—adrenal gland cancer	2.78e-05	0.000372	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TERT—adrenal gland cancer	2.59e-05	0.000347	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—CTNNB1—adrenal gland cancer	2.57e-05	0.000344	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SDHB—adrenal gland cancer	2.49e-05	0.000333	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—GNAS—adrenal gland cancer	2.42e-05	0.000324	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—ABCB1—adrenal gland cancer	2.38e-05	0.000318	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—CTNNB1—adrenal gland cancer	2.35e-05	0.000315	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BAD—adrenal gland cancer	2.26e-05	0.000302	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—PRKACA—adrenal gland cancer	2.24e-05	0.000299	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—POMC—adrenal gland cancer	2.08e-05	0.000278	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—BRAF—adrenal gland cancer	2.05e-05	0.000275	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—EGFR—adrenal gland cancer	2.04e-05	0.000273	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CDC42—adrenal gland cancer	1.9e-05	0.000254	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—EGFR—adrenal gland cancer	1.86e-05	0.000249	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF2—adrenal gland cancer	1.83e-05	0.000244	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—GNAS—adrenal gland cancer	1.81e-05	0.000242	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—IGF1R—adrenal gland cancer	1.77e-05	0.000236	CbGpPWpGaD
Danazol—CCL2—Signaling Pathways—TP53—adrenal gland cancer	1.71e-05	0.000229	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—POMC—adrenal gland cancer	1.63e-05	0.000218	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—RRM1—adrenal gland cancer	1.6e-05	0.000214	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—SDHD—adrenal gland cancer	1.6e-05	0.000214	CbGpPWpGaD
Danazol—GNRHR—Signaling Pathways—TP53—adrenal gland cancer	1.57e-05	0.000209	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TERT—adrenal gland cancer	1.52e-05	0.000203	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—CTNNB1—adrenal gland cancer	1.48e-05	0.000198	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BAD—adrenal gland cancer	1.32e-05	0.000177	CbGpPWpGaD
Danazol—CYP19A1—Metabolism—PTGS2—adrenal gland cancer	1.3e-05	0.000174	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—POMC—adrenal gland cancer	1.22e-05	0.000163	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—BRAF—adrenal gland cancer	1.21e-05	0.000161	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—MED12—adrenal gland cancer	1.2e-05	0.00016	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—EGFR—adrenal gland cancer	1.18e-05	0.000157	CbGpPWpGaD
Danazol—PGR—Signaling Pathways—TP53—adrenal gland cancer	9.87e-06	0.000132	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PRKACA—adrenal gland cancer	8.72e-06	0.000117	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—CTNNB1—adrenal gland cancer	8.71e-06	0.000116	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—GNAS—adrenal gland cancer	7.07e-06	9.45e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—ABCB1—adrenal gland cancer	6.94e-06	9.27e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—EGFR—adrenal gland cancer	6.9e-06	9.23e-05	CbGpPWpGaD
Danazol—ESR1—Signaling Pathways—TP53—adrenal gland cancer	5.79e-06	7.75e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—POMC—adrenal gland cancer	4.76e-06	6.36e-05	CbGpPWpGaD
Danazol—CYP3A4—Metabolism—PTGS2—adrenal gland cancer	3.8e-06	5.07e-05	CbGpPWpGaD
